Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
BioNTech SE(BNTX) Newsfilter·2024-06-27 22:302 European Medicines Agency (EMA) ETF recommends updating COVID-19 vaccines to target new JN.1 variant. 30 April 2024. Available at: https://www.ema.europa.eu/en/news/etf-recommends-updating-covid-19- vaccines-target-new-jn1-variant (Accessed 26.06.2024). BioNTech: Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 Media@biontech.de Investor Relations Victoria Meissner, M.D. +1 617 528 8293 Investors@biontech.de ---------- 1 World Health Organization (WHO) Statement on the antigen composition of COVID-1 ...